Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mariët J. van der Werf is active.

Publication


Featured researches published by Mariët J. van der Werf.


The EMBO Journal | 2003

Structure of Rhodococcus erythropolis limonene-1,2-epoxide hydrolase reveals a novel active site

Michael Arand; B. Martin Hallberg; Jinyu Zou; Terese Bergfors; Franz Oesch; Mariët J. van der Werf; Jan A. M. de Bont; T. Alwyn Jones; Sherry L. Mowbray

Epoxide hydrolases are essential for the processing of epoxide‐containing compounds in detoxification or metabolism. The classic epoxide hydrolases have an α/β hydrolase fold and act via a two‐step reaction mechanism including an enzyme–substrate intermediate. We report here the structure of the limonene‐1,2‐epoxide hydrolase from Rhodococcus erythropolis, solved using single‐wavelength anomalous dispersion from a selenomethionine‐substituted protein and refined at 1.2 Å resolution. This enzyme represents a completely different structure and a novel one‐step mechanism. The fold features a highly curved six‐stranded mixed β‐sheet, with four α‐helices packed onto it to create a deep pocket. Although most residues lining this pocket are hydrophobic, a cluster of polar groups, including an Asp–Arg–Asp triad, interact at its deepest point. Site‐directed mutagenesis supports the conclusion that this is the active site. Further, a 1.7 Å resolution structure shows the inhibitor valpromide bound at this position, with its polar atoms interacting directly with the residues of the triad. We suggest that several bacterial proteins of currently unknown function will share this structure and, in some cases, catalytic properties.


FEBS Letters | 1998

THE RHODOCOCCUS ERYTHROPOLIS DCL14 LIMONENE-1,2-EPOXIDE HYDROLASE GENE ENCODES AN ENZYME BELONGING TO A NOVEL CLASS OF EPOXIDE HYDROLASES

Fabien Barbirato; Jan C. Verdoes; Jan A. M. de Bont; Mariët J. van der Werf

Recently, we reported the purification of the novel enzyme limonene‐1,2‐epoxide hydrolase involved in limonene degradation by Rhodococcus erythropolis DCL14. The N‐terminal amino acid sequence of the purified enzyme was used to design two degenerate primers at the beginning and the end of the 50 amino acids long stretch. Subsequently, the complete limonene‐1,2‐epoxide hydrolase gene (limA) was isolated from a genomic library of R. erythropolis DCL14 using a combination of PCR and colony hybridization. The limA gene encoded a 149‐residue polypeptide with a deduced molecular mass of 16.5 kDa. It was functionally expressed in Escherichia coli. The amino acid sequence of limA contains neither any of the conserved regions of the α,β‐hydrolase fold enzymes, to which most of the previously reported epoxide hydrolases belong, nor any of the conserved motifs present in leukotriene A4 hydrolase. The structural data presented in this paper confirm previous physical and biochemical findings [van der Werf et al. (1998) J. Bacteriol. 180, 5052–5057] that limonene‐1,2‐epoxide hydrolase is the first member of a new class of epoxide hydrolases.


Trends in Biotechnology | 1994

The potential of lyases for the industrial production of optically active compounds

Mariët J. van der Werf; Will J.J. van den Tweel; Johan Kamphuis; S. Hartmans; Jan A. M. de Bont

Lyases catalyse the cleavage of C-C, C-N, C-O and other bonds by elimination to produce double bonds or, conversely, catalyse the addition of groups to double bonds. These enzymes do not require cofactor recycling, show an absolute stereospecificity and can give a theoretical yield of 100%, compared with only 50% for enantiomeric resolutions. Lyases are therefore attracting considerable interest as biocatalysts for the production of optically active compounds, and have already found application in several large commercial processes.


Journal of Biotechnology | 2000

Xanthobacter sp. C20 contains a novel bioconversion pathway for limonene

Mariët J. van der Werf; Paula M Keijzer; Peter H van der Schaft

Xanthobacter sp. C20 was isolated from sediment of the river Rhine using cyclohexane as sole source of carbon and energy. Xanthobacter sp. C20 converted both enantiomers of limonene quantitatively into limonene-8,9-epoxide, a not previously described bioconversion product of limonene. With (4R)-limonene, (4R,8R)-limonene-8, 9-epoxide was formed as the only reaction product, while (4S)-limonene was converted into a (78:22) mixture of (4S,8R)- and (4S,8S)-limonene-8,9-epoxide. Cytochrome P-450 was shown to be induced concomitantly with limonene bioconversion activity following growth of Xanthobacter sp. C20 on cyclohexane. Maximal limonene bioconversion rate was observed at an initial substrate concentration of 12 mM. The amount of limonene-8,9-epoxide formed, up to 0.8 g l(-1), was limited by a strong product inhibition.


Applied and Environmental Microbiology | 2001

Genetic and biochemical characterization of a novel monoterpene ε-lactone hydrolase from Rhodococcus erythropolis DCL14

Cécile J. B van der Vlugt-Bergmans; Mariët J. van der Werf

A monoterpene e-lactone hydrolase (MLH) from Rhodococcus erythropolis DCL14, catalyzing the ring opening of lactones which are formed during degradation of several monocyclic monoterpenes, including carvone and menthol, was purified to apparent homogeneity. It is a monomeric enzyme of 31 kDa that is active with (4R)-4-isopropenyl-7-methyl-2-oxo-oxepanone and (6R)-6-isopropenyl-3-methyl-2-oxo-oxepanone, lactones derived from (4R)-dihydrocarvone, and 7-isopropyl-4-methyl-2-oxo-oxepanone, the lactone derived from menthone. Both enantiomers of 4-, 5-, 6-, and 7-methyl-2-oxo-oxepanone were converted at equal rates, suggesting that the enzyme is not stereoselective. Maximal enzyme activity was measured at pR 9.5 and 30°C. Determination of the N-terminal amino acid sequence of purified MLH enabled cloning of the corresponding gene by a combination of PCR and colony screening. The gene, designated mlhB (monoterpene lactone hydrolysis), showed up to 43% similarity to members of the GDXG family of lipolytic enzymes. Sequencing of the adjacent regions revealed two other open reading frames, one encoding a protein with similarity to the short-chain dehydrogenase reductase family and the second encoding a protein with similarity to acyl coenzyme A dehydrogenases. Both enzymes are possibly also involved in the monoterpene degradation pathways of this microorganism. Molecular Sequence Numbers: EMBL: AJ292535; GENBANK: AJ292535;ABSTRACT A monoterpene ɛ-lactone hydrolase (MLH) from Rhodococcus erythropolis DCL14, catalyzing the ring opening of lactones which are formed during degradation of several monocyclic monoterpenes, including carvone and menthol, was purified to apparent homogeneity. It is a monomeric enzyme of 31 kDa that is active with (4R)-4-isopropenyl-7-methyl-2-oxo-oxepanone and (6R)-6-isopropenyl-3-methyl-2-oxo-oxepanone, lactones derived from (4R)-dihydrocarvone, and 7-isopropyl-4-methyl-2-oxo-oxepanone, the lactone derived from menthone. Both enantiomers of 4-, 5-, 6-, and 7-methyl-2-oxo-oxepanone were converted at equal rates, suggesting that the enzyme is not stereoselective. Maximal enzyme activity was measured at pH 9.5 and 30°C. Determination of the N-terminal amino acid sequence of purified MLH enabled cloning of the corresponding gene by a combination of PCR and colony screening. The gene, designated mlhB(monoterpene lactone hydrolysis), showed up to 43% similarity to members of the GDXG family of lipolytic enzymes. Sequencing of the adjacent regions revealed two other open reading frames, one encoding a protein with similarity to the short-chain dehydrogenase reductase family and the second encoding a protein with similarity to acyl coenzyme A dehydrogenases. Both enzymes are possibly also involved in the monoterpene degradation pathways of this microorganism.


Applied and Environmental Microbiology | 1999

Rhodococcus erythropolis DCL14 contains a novel degradation pathway for limonene.

Mariët J. van der Werf; Henk J. Swarts; Jan A. M. de Bont


Trends in Biotechnology | 2003

What can spores do for us

Wout A. M. Wolken; J. Tramper; Mariët J. van der Werf


Trends in Biotechnology | 2005

Towards replacing closed with open target selection strategies

Mariët J. van der Werf


Biotechnology and Bioengineering | 2002

Toxicity of terpenes to spores and mycelium of Penicillium digitatum

Wout A. M. Wolken; J. Tramper; Mariët J. van der Werf


FEBS Journal | 2002

A novel, inducible, citral lyase purified from spores of Penicillium digitatum

Wout A. M. Wolken; Willem J. V. Van Loo; J. Tramper; Mariët J. van der Werf

Collaboration


Dive into the Mariët J. van der Werf's collaboration.

Top Co-Authors

Avatar

Jan A. M. de Bont

Wageningen University and Research Centre

View shared research outputs
Top Co-Authors

Avatar

J. Tramper

Wageningen University and Research Centre

View shared research outputs
Top Co-Authors

Avatar

Wout A. M. Wolken

Wageningen University and Research Centre

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge